The Direct Index
Report · scanned 2026-10-23

What an AI agent reads on New England Medical Research

An assistant's crawler fetches the page once, without running JavaScript, and reads the text, the structured data and the links. Below is what it gets from nejm.org, taken from the copy the scanner kept.

12,764

characters of text without JavaScript

none

structured data for the business

3

of 3 AI crawlers turned away at the edge (GPTBot, ClaudeBot, PerplexityBot)

Text

The words an agent gets

Title: The New England Journal of Medicine | Research & Review Articles on Disease & Clinical Practice · language en. First 1,800 of 12,764 characters:

The New England Journal of Medicine | Research & Review Articles on Disease & Clinical Practice Skip to main content The New England Journal of MedicineNEJM NEJM Clinician NEJM Evidence NEJM AI NEJM Catalyst NEJM Voices Sign In|Create AccountSubscribe current issueVIEW CURRENT ISSUEBROWSE RECENTLY PUBLISHEDBROWSE ALL ISSUESSPECIALTIESCardiologyClinical MedicineEndocrinologyGastroenterologyHematology/OncologyInfectious DiseaseNephrologyNeurology/NeurosurgeryObstetrics/GynecologyPediatricsPulmonary/Critical CareSurgeryView All SpecialtiesTOPICSAI in MedicineClimate ChangeCoronavirusCorporatization of Health CareEfforts toward EquityFirearm Injury PreventionFrom the National Academy of MedicineGray MattersHealth PolicyMedicine and SocietyNutrition in MedicineOutbreaks CenterRace and MedicineTobacco Use ReductionView All TopicsMULTIMEDIAPodcastsDouble TakesDr. Glaucomflecken ExplainsIllustrated GlossaryImage ChallengeImages in Clinical MedicineInteractive Medical CasesResearch SummariesQuick TakesVideos in Clinical MedicineView All MultimediaLEARNING/CMECase ChallengesMedical EducationWeekly CMEVIEW ALL LEARNING/CMEAUTHOR CENTER Advanced SearchSEARCH SaveOriginal ArticleMeeting of the American Society of NephrologyAtacicept in IgA Nephropathy — Final Efficacy AnalysisJ. Barratt and OthersIn patients with IgA nephropathy, atacicept, a human TACI–Fc fusion protein that modulates B-cell activity, slowed and stabilized the decline in the eGFR as compared with placebo. SaveOriginal ArticleMeeting of the American Society of NephrologySibeprenlimab in IgA NephropathyD.V. Rizk and OthersIn this phase 3, double-blind, randomized trial involving patients with IgA nephropathy, sibeprenlimab stabilized the eGFR slope over 24 months, consistent with a reduced risk of kidney-functi
Facts

What it can say about the business

A business type in JSON-LDno
Nameno
Telephoneno
Addressno
Opening hoursno
Menu or price listnothing
Cuisine in structured datano
JSON-LD blocks1 (SearchAction, WebSite)
Actions

The links it would act on

LinkRoleWhere it goes
catalyst.nejm.org/orderingthe business's own site

Everything here comes from fetching the homepage once as a crawler. The report turns it into a score and a list of fixes, with code to paste.